Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 43 most recent Form 4 transactions.
| Aug 10 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 679 | $8.04 | $5.5K | +1.3% | Open the original filing on SEC.gov |
| Jul 27 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 1,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 27 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 1,000 | $20.00 | $20K | -1.9% | Open the original filing on SEC.gov |
| Jul 27 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 1,000 | $12.65 | $12.7K | +1.9% | Open the original filing on SEC.gov |
| Jun 30 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 1,779 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 2,875 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 4,654 | $20.00 | $93.1K | -8.3% | Open the original filing on SEC.gov |
| Jun 30 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 1,779 | $8.04 | $14.3K | +3.3% | Open the original filing on SEC.gov |
| Jun 30 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 2,875 | $12.65 | $36.4K | +5.5% | Open the original filing on SEC.gov |
| Jun 23 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 1,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 23 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 1,450 | $18.00 | $26.1K | -2.7% | Open the original filing on SEC.gov |
| Jun 23 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 1,450 | $8.04 | $11.7K | +2.8% | Open the original filing on SEC.gov |
| Jun 16 | CGEM | Cullinan Therapeutics,… | AGRANT◆ | 21,781 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | AVTX | Avalo Therapeutics, Inc. | FTAX | 1,084 | $13.10 | $14.2K | -2.1% | Open the original filing on SEC.gov |
| May 28 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 679 | — | — | — | Open the original filing on SEC.gov |
| May 28 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 679 | $16.00 | $10.9K | -1.4% | Open the original filing on SEC.gov |
| May 28 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 679 | $8.04 | $5.5K | +1.4% | Open the original filing on SEC.gov |
| May 21 | AVTX | Avalo Therapeutics, Inc. | AGRANT | 43,500 | — | — | +1,201% | Open the original filing on SEC.gov |
| May 15 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| May 15 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 3,000 | $18.76 | $56.3K | -45.3% | Open the original filing on SEC.gov |
| May 15 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 3,000 | $12.65 | $38K | +82.8% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 28,650 | — | — | — | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 77,905 | — | — | — | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 10,058 | $22.88 | $230.1K | -73.5% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 19,015 | $22.41 | $426.1K | -58.2% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 44,944 | $21.20 | $952.7K | -57.9% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 5,000 | $19.65 | $98.3K | -6.0% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 27,538 | $18.03 | $496.4K | -25.0% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 28,650 | $8.04 | $230.3K | +35.1% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 77,905 | $12.65 | $985.5K | +2,151% | Open the original filing on SEC.gov |
| May 5 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 679 | — | — | — | Open the original filing on SEC.gov |
| May 5 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 1,000 | — | — | — | Open the original filing on SEC.gov |
| May 5 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 1,679 | $16.00 | $26.9K | -31.7% | Open the original filing on SEC.gov |
| May 5 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 679 | $8.04 | $5.5K | +14.7% | Open the original filing on SEC.gov |
| May 5 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 1,000 | $12.65 | $12.7K | +27.6% | Open the original filing on SEC.gov |
| Apr 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 3,970 | — | — | — | Open the original filing on SEC.gov |
| Apr 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 3,970 | $18.01 | $71.5K | -52.3% | Open the original filing on SEC.gov |
| Apr 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 3,970 | $12.65 | $50.2K | +109.6% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 679 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 679 | $16.00 | $10.9K | -15.8% | Open the original filing on SEC.gov |
| Apr 1 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 679 | $8.04 | $5.5K | +18.8% | Open the original filing on SEC.gov |